PharmAla Biotech Holdings on JUNS, Oct 26, 2026

PharmAla Biotech Holdings cut its stake to 10.1% (from 17.3%), as a passive investor.

Date
Oct 26, 2026
Who
PharmAla Biotech Holdings
Fund
JUNS - Jupiter Neurosciences
Stake
10.1% (132,867 shares)
Type of notice
Updated notice
Document number
0000912282-26-001403

Open the original document at the SEC →

We read this document automatically. If something looks wrong, the original is the one that counts.

Back to JUNS